Krebs Biochemicals and Industries Limited has informed the Exchange regarding Cessation of Jitendra Shah as Managing Director & CEO of the company w.e.f. August 07, 2025.
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.7 pts less than Nifty Microcap 250 and 3.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Krebs Biochemicals and Industries Limited has informed the stock exchanges that Mr. Jitendra Shah (DIN: 09377846) has resigned from the post of Managing Director & CEO, effective from the close of business hours on August 7, 2025. The resignation is stated to be for personal reasons, and he has confirmed there are no other reasons for stepping down. Mr. Shah has also resigned as a Director on the board. He was appointed relatively recently, given the DIN sequence suggesting tenure from a few years ago. The company has requested the exchanges to take the intimation on record under SEBI Listing Regulations.
The sudden exit of the top leadership—Managing Director & CEO as well as Director—may create short-term uncertainty around strategic direction and continuity. Shareholders should watch for an announcement regarding the appointment of a replacement CEO, as prolonged leadership vacancy in a small-cap company can affect investor confidence and stock price sentiment.